You just read:

Helsinn Group to Present at ASCO Pooled Follow up Efficacy Data Analysis From two Phase III Studies for Anamorelin in Cachectic Patients With Non-small Cell Lung Cancer (NSCLC)

News provided by

Helsinn

01 Jun, 2016, 14:00 BST